Critical Analysis – Before Investing in Altria, Read This Report!

Shares of Altria have moved -1.0% today, and are now trading at a price of $44.32. In contrast, the S&P 500 index saw a 0.0% change. Today's trading volume is 10,273,809 compared to the stock's average volume of 12,172,269.

Altria Group, Inc., through its subsidiaries, manufactures and sells smokeable and oral tobacco products in the United States. Based in Richmond, United States the company has 6,400 full time employees and a market cap of $76,125,356,032. Altria currently offers its equity investors a dividend that yields 8.7% per year.

The company is now trading 2.85% away from its average analyst target price of $43.09 per share. The 13 analysts following the stock have set target prices ranging from $33.76 to $67.51, and on average give Altria a rating of hold.

Over the last 52 weeks, MO stock has risen 3.8%, which amounts to a -19.4% difference compared to the S&P 500. The stock's 52 week high is $47.19 whereas its 52 week low is $39.07 per share. Based on Altria's average net margin growth of 3.5% over the last 6 years, its core business is on track for profitability and its strong stock performance may continue in the long term.

Date Reported Total Revenue ($ k) Net Profit ($ k) Net Margins (%) YoY Growth (%)
2023 24,483,000 8,130,000 33 43.48
2022 25,096,000 5,764,000 23 130.0
2021 26,013,000 2,475,000 10 -41.18
2020 26,153,000 4,467,000 17 440.0
2019 25,110,000 -1,293,000 -5 -118.52
2018 25,364,000 6,963,000 27
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.